Subscribe

What are you looking for?

Main Menu

明報新聞網

信達生物創新高 野村稱純利增長超預期

Future Wealths
Future Wealths
26 8 月, 2026
One Min Read
1 Views
0 Comments
信達生物製藥(1801)曾升逾12%至112.7元，創上市新高。彭博報道，信達中期收入增45%至86億元人民幣(下同)，雖然總收入低於預期，但野村稱淨利潤增長超預期。

原文: https://finance.mingpao.com/fin/instantf/20260826/1787710770866/%E4%BF%A1%E9%81%94%E7%94%9F%E7%89%A9%E5%89%B5%E6%96%B0%E9%AB%98-%E9%87%8E%E6%9D%91%E7%A8%B1%E7%B4%94%E5%88%A9%E5%A2%9E%E9%95%B7%E8%B6%85%E9%A0%90%E6%9C%9F%22%20target=%22blank

Last Update: 26 8 月, 2026

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept